Ex vivo expansion of cord blood
暂无分享,去创建一个
[1] C. Eaves,et al. Direct evidence for multiple self-renewal divisions of human in vivo repopulating hematopoietic cells in short-term culture. , 1999, Blood.
[2] M. Cilli,et al. Evaluation of ex vivo expansion and engraftment in NOD-SCID mice of umbilical cord blood CD34+ cells using the DIDECO ‘Pluricell System’ , 2005, Bone Marrow Transplantation.
[3] J. Hows,et al. Adult bone marrow is a rich source of human mesenchymal ‘stem’ cells but umbilical cord and mobilized adult blood are not , 2003, British journal of haematology.
[4] J. Bussel,et al. Long-Term Treatment with Romiplostim in Patients with Chronic Immune Thrombocytopenic Purpura (ITP): 3-Year Update from An Open-Label , 2008 .
[5] O. Ringdén,et al. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. , 2003, Experimental hematology.
[6] J. Wagner,et al. Results of the cord blood transplantation study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[7] Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. , 1996, The New England journal of medicine.
[8] S. Gerson,et al. Phenotypic and functional comparison of cultures of marrow‐derived mesenchymal stem cells (MSCs) and stromal cells , 1998, Journal of cellular physiology.
[9] M. Yamaguchi,et al. Bone marrow stromal cells prepared using AB serum and bFGF for hematopoietic stem cells expansion , 2002, Transfusion.
[10] I. Bernstein,et al. Notch-Mediated Expansion of Human Cord Blood Progenitor Cells Results in Rapid Myeloid Reconstitution in Vivo Following Myeloablative Cord Blood Transplantation , 2008 .
[11] W. Piacibello,et al. Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells. , 1999, Blood.
[12] P. Greengard,et al. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor , 2004, Nature Medicine.
[13] M. Yamaguchi,et al. Serum-free coculture system for ex vivo expansion of human cord blood primitive progenitors and SCID mouse-reconstituting cells using human bone marrow primary stromal cells. , 2001, Experimental hematology.
[14] J. Dick,et al. Distinct classes of human stem cells that differ in proliferative and self-renewal potential , 2001, Nature Immunology.
[15] I. Lemischka,et al. The return of clonal marking sheds new light on human hematopoietic stem cells , 2001, Nature Immunology.
[16] P. Fu,et al. Expansion of LTC‐ICs and Maintenance of p21 and BCL‐2 Expression in Cord Blood CD34+/CD38− Early Progenitors Cultured over Human MSCs as a Feeder Layer , 2002, Stem cells.
[17] Pingfu Fu,et al. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. , 2003, Blood.
[18] S. Feig,et al. Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. , 2008, Blood.
[19] P. Rebulla,et al. Comparison of different serum‐free media for ex vivo expansion of HPCs from cord blood using thrombopoietin, Flt‐3 ligand, IL‐6, and IL‐11 , 2001, Transfusion.
[20] R. Deans,et al. Mesenchymal stem cells: biology and potential clinical uses. , 2000, Experimental hematology.
[21] A. Nagler,et al. Umbilical cord blood transplantation--how, when and for whom? , 2004, Blood reviews.
[22] J. Adamson,et al. CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC only. TRIALS , 2022 .
[23] C. Eaves,et al. Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G(2)/M transit and do not reenter G(0). , 2000, Blood.
[24] E. Shpall,et al. Double Cord Blood Transplantation (CBT) With Ex-Vivo Expansion (EXP) of One Unit Utilizing A Mesenchymal Stromal Cell (MSC) Platform , 2009 .
[25] S. Chevret,et al. Results of unrelated umbilical cord blood hematopoietic stem cell transplantation. , 2001, Reviews in clinical and experimental hematology.
[26] A. Nagler,et al. Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial , 2008, Bone Marrow Transplantation.
[27] M. Koller,et al. Bioreactor expansion of human bone marrow: comparison of unprocessed, density-separated, and CD34-enriched cells. , 1995, Journal of hematotherapy.
[28] R. Willemze,et al. Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. , 2003, Haematologica.
[29] Lesley J. Murray,et al. Thrombopoietin stimulates megakaryocytopoiesis, myelopoiesis, and expansion of CD34+ progenitor cells from single CD34+Thy-1+Lin− primitive progenitor cells , 1996 .
[30] Lesley J. Murray,et al. Thrombopoietin stimulates megakaryocytopoiesis, myelopoiesis, and expansion of CD34+ progenitor cells from single CD34+Thy-1+Lin- primitive progenitor cells. , 1996, Blood.
[31] I McNiece,et al. Increased expansion and differentiation of cord blood products using a two-step expansion culture. , 2000, Experimental hematology.
[32] A. von Drygalski,et al. Murine bone marrow cells cultured ex vivo in the presence of multiple cytokine combinations lose radioprotective and long-term engraftment potential. , 2004, Stem cells and development.
[33] D. Heath,et al. Expression Profiling and Functional Analysis of Wnt Signaling Mechanisms in Mesenchymal Stem Cells , 2004, Stem cells.
[34] L. Lajtha,et al. Conditions controlling the proliferation of haemopoietic stem cells in vitro , 1977, Journal of cellular physiology.
[35] C. Voermans,et al. Wnt signaling in the stem cell niche , 2004, Current opinion in hematology.
[36] T. Dexter,et al. Prolonged hematopoiesis in a primate bone marrow culture system: characteristics of stem cell production and the hematopoietic microenvironment. , 1979, Blood.
[37] Hal E. Broxmeyer,et al. Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation. , 2000 .
[38] J. Vávrová,et al. Ex vivo expansion CD34+/AC133+-selected autologous peripheral blood progenitor cells (PBPC) in high-risk breast cancer patients receiving intensive chemotherapy. , 1999, Hematology and cell therapy.
[39] R. Willemze,et al. Nonexpanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. , 2003, Experimental hematology.
[40] J. Chang,et al. Long-term bone marrow cultures: their use in autologous marrow transplantation. , 1989, Cancer cells.
[41] E. Shpall,et al. Differential long-term and multilineage engraftment potential from subfractions of human CD34+ cord blood cells transplanted into NOD/SCID mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[42] S. Chevret,et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. , 2004, Experimental hematology.
[43] J. Wagner,et al. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. , 2003, Blood.
[44] J. Vávrová,et al. Myeloid differentiation and maturation of SCF+IL-3+IL-11 expanded AC133+/CD34+ cells selected from high-risk breast cancer patients. , 2000, Neoplasma.
[45] H. Gouda,et al. Ex vivo expansion of stem cells: defining optimum conditions using various cytokines. , 2006, Laboratory hematology : official publication of the International Society for Laboratory Hematology.
[46] Z. Han,et al. Short-term ex vivo expansion sustains the homing-related properties of umbilical cord blood hematopoietic stem and progenitor cells. , 2004, Haematologica.
[47] A. Wolfberg,et al. Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[48] S. Tsai,et al. Isolation of a human stromal cell strain secreting hemopoietic growth factors , 1986, Journal of cellular physiology.
[49] A. Nagler,et al. Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine. , 2004, Cytotherapy.
[50] Todd E DeFor,et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. , 2005, Blood.
[51] I-Ming Chu,et al. A systematic strategy to optimize ex vivo expansion medium for human hematopoietic stem cells derived from umbilical cord blood mononuclear cells. , 2004, Experimental hematology.
[52] F. Claas,et al. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. , 2003, Blood.
[53] M. Yamaguchi,et al. Ex vivo expansion of human UC blood primitive hematopoietic progenitors and transplantable stem cells using human primary BM stromal cells and human AB serum. , 2002, Cytotherapy.
[54] C. Heyworth,et al. AC133+ G0 Cells from Cord Blood Show a High Incidence of Long‐Term Culture–Initiating Cells and a Capacity for More Than 100 Million‐Fold Amplification of Colony‐Forming Cells In Vitro , 2004, Stem cells.
[55] T. Dexter,et al. Metabolically inactive 3T3 cells can substitute for marrow stromal cells to promote the proliferation and development of multipotent haemopoietic stem cells , 1987, Journal of cellular physiology.
[56] C. Heyworth,et al. Cord Blood G0 CD34+ Cells Have A Thousand‐Fold Higher Capacity For Generating Progenitors In Vitro Than G1 CD34+ Cells , 2001 .
[57] J. Falkenburg,et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. , 2002, Experimental hematology.
[58] F. Hirayama,et al. Stromal cell-dependent ex vivo expansion of human cord blood progenitors and augmentation of transplantable stem cell activity , 2000, Bone Marrow Transplantation.
[59] J. Wagner,et al. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[60] O. Ringdén,et al. Immunologic properties of human fetal mesenchymal stem cells. , 2004, American journal of obstetrics and gynecology.
[61] Ariane Tormin,et al. Mesenchymal Stem Cell Content of Human Vertebral Bone Marrow , 2004, Transplantation.
[62] P. Stiff,et al. A phase II trial evaluating the safety and effectiveness of the AastromReplicell system for augmentation of low-dose blood stem cell transplantation , 2001, Bone Marrow Transplantation.
[63] J. Chang,et al. Stromal cells in haemopoiesis. , 1990, Ciba Foundation symposium.
[64] D. Higby,et al. Transplantation of unrelated cord blood cells , 1998, Bone Marrow Transplantation.
[65] C. Chastang,et al. Outcome of cord-blood transplantation from related and unrelated donors , 1997 .
[66] Haiyang Huang,et al. Identification of the haematopoietic stem cell niche and control of the niche size , 2003, Nature.
[67] S. Ramin,et al. Mesenchymal stem cells from the Wharton's jelly of umbilical cord segments provide stromal support for the maintenance of cord blood hematopoietic stem cells during long‐term ex vivo culture , 2008, Transfusion.
[68] G. van Zant,et al. Expansion in bioreactors of human progenitor populations from cord blood and mobilized peripheral blood. , 1994, Blood cells.
[69] A. Nagler,et al. Unrelated and related cord blood banking and hematopoietic graft engineering , 2004, Cell and Tissue Banking.
[70] R. Schofield. The stem cell system. , 1983, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[71] E. Fitzsimons,et al. CD34 positive PBPC expanded ex vivo may not provide durable engraftment following myeloablative chemoradiotherapy regimens , 1997, Bone Marrow Transplantation.
[72] C. Verfaillie,et al. Umbilical cord blood cells capable of engrafting in primary, secondary, and tertiary xenogeneic hosts are preserved after ex vivo culture in a noncontact system. , 2001, Blood.
[73] Lesley J. Murray,et al. Thrombopoietin, flt3, and kit ligands together suppress apoptosis of human mobilized CD34+ cells and recruit primitive CD34+ Thy-1+ cells into rapid division. , 1999, Experimental hematology.
[74] D. Williams. Ex vivo expansion of hematopoietic stem and progenitor cells--robbing Peter to pay Paul? [editorial] , 1993 .
[75] O. Ringdén,et al. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells , 2003, Transplantation.
[76] S. Emerson,et al. Large-scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion cultures. , 1993, Blood.
[77] H. Broxmeyer,et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[78] P. Rebulla,et al. Evaluation of the effect of cryopreservation on ex vivo expansion of hematopoietic progenitors from cord blood , 2001, Bone Marrow Transplantation.
[79] J. García,et al. Cord blood transplants: early recovery of neutrophils from co-transplanted sibling haploidentical progenitor cells and lack of engraftment of cultured cord blood cells, as ascertained by analysis of DNA polymorphisms , 2001, Bone Marrow Transplantation.
[80] J. Segovia,et al. Delayed Engraftment of Nonobese Diabetic/Severe Combined Immunodeficient Mice Transplanted With Ex Vivo–Expanded Human CD34+ Cord Blood Cells , 1999 .
[81] E. Shpall,et al. Ex-vivo expansion of hematopoietic progenitor cells: preliminary results in breast cancer. , 1999, Hematology and cell therapy.
[82] J. Chang,et al. Cord blood G(0) CD34+ cells have a thousand-fold higher capacity for generating progenitors in vitro than G(1) CD34+ cells. , 2001, Stem cells.
[83] I. Bernstein,et al. Dose-dependent effects of the Notch ligand Delta1 on ex vivo differentiation and in vivo marrow repopulating ability of cord blood cells. , 2005, Blood.
[84] T. Dexter,et al. The essential cells of the hemopoietic microenvironment. , 1984, Experimental hematology.
[85] Chan Zeng,et al. Transplantation of ex vivo expanded cord blood. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[86] Giuseppe Puglisi,et al. Long‐term expansion and maintenance of cord blood haematopoietic stem cells using thrombopoietin, Flt3‐ligand, interleukin (IL)‐6 and IL‐11 in a serum‐free and stroma‐free culture system , 2001, British journal of haematology.
[87] E. Shpall,et al. Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer. , 2000, Blood.
[88] Christian J Stoeckert,et al. A molecular profile of a hematopoietic stem cell niche , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[89] D. Wright,et al. An analysis of the multilineage production of human hematopoietic progenitors in long-term bone marrow culture: evidence that reactive oxygen intermediates derived from mature phagocytic cells have a role in limiting progenitor cell self-renewal. , 1988, Blood.
[90] Alan K. Smith,et al. UMBILICAL CORD BLOOD TRANSPLANTS IN ADULTS USING A COMBINATION OF UNEXPANDED AND EX VIVO EXPANDED CELLS: PRELIMINARY CLINICAL OBSERVATIONS , 1998 .
[91] Dexter Tm,et al. Haemopoietic microenvironments in vitro--which cells are involved? , 1984 .
[92] E. Shpall,et al. Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential. , 2002, Experimental hematology.
[93] C. Chastang,et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. , 1997, The New England journal of medicine.
[94] K. Moore,et al. Stem cells: Interactive niches , 2003, Nature.
[95] H. Kaplan,et al. Long-term culture of human bone marrow cells. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[96] K. Le Blanc. Immunomodulatory effects of fetal and adult mesenchymal stem cells. , 2003, Cytotherapy.
[97] S. Heimfeld,et al. Large volume ex vivo expansion of CD34-positive hematopoietic progenitor cells for transplantation. , 1995, Journal of hematotherapy.
[98] Moustapha Hassan,et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells , 2004, The Lancet.
[99] P. Simmons,et al. Improved haematopoietic recovery following transplantation with ex vivo‐expanded mobilized blood cells * , 2004, British journal of haematology.
[100] A. Nagler,et al. Erratum: Cellular copper content modulates differentiation and self-renewal in cultures of cord blood-derived CD34+ cells (British Journal of Haematology 116:3 (655-661)) , 2002 .
[101] A. Nagler,et al. Linear polyamine copper chelator tetraethylenepentamine augments long-term ex vivo expansion of cord blood-derived CD34+ cells and increases their engraftment potential in NOD/SCID mice. , 2004, Experimental hematology.
[102] M. Conconi,et al. New immortalized human stromal cell lines enhancing in vitro expansion of cord blood hematopoietic stem cells. , 2004, International journal of molecular medicine.
[103] J. Wagner,et al. Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. , 2001, The New England journal of medicine.
[104] YingWu,et al. Human placenta-derived mesenchymal progenitor cells support culture expansion of long-term culture-initiating cells from cord blood CD34^+ cells , 2005 .
[105] T. Dexter,et al. Cellular interactions between 3T3 cells and interleukin‐3‐dependent multipotent haemopoietic cells: A model system for stromal‐cell‐mediated haemopoiesis , 1989, Journal of cellular physiology.
[106] S. Karandish,et al. Double‐chimaerism after transplantation of two human leucocyte antigen mismatched, unrelated cord blood units , 2002, British journal of haematology.
[107] W. Piacibello,et al. Elevated telomerase activity and minimal telomere loss in cord blood long-term cultures with extensive stem cell replication. , 2004, Blood.
[108] M. Clarke,et al. In vitro expansion of hematopoietic cells for clinical application. , 1995, Cancer treatment and research.
[109] D. Gao,et al. Cord blood transplant in childhood ALL , 2005, Pediatric blood & cancer.
[110] L. Lajtha,et al. Stimulation of differentiation and proliferation of haemopoietic cells in vitro , 1973, Journal of cellular physiology.
[111] Dexter Tm,et al. The essential cells of the hemopoietic microenvironment , 1984 .
[112] E. Shpall,et al. Ex vivo expansion of cord blood mononuclear cells on mesenchymal stem cells. , 2004, Cytotherapy.
[113] J. Kurtzberg,et al. Human umbilical cord blood: a clinically useful source of transplantable hematopoietic stem/progenitor cells. , 1990, International journal of cell cloning.
[114] J. Segovia,et al. Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells. , 1999, Blood.
[115] O. Ringdén,et al. Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells , 2003, Bone Marrow Transplantation.
[116] D. Niedzwiecki,et al. Immune reconstitution after unrelated cord blood transplantation. , 2007, Cytotherapy.
[117] Shiaw-Min Hwang,et al. Characterization of serum-free ex vivo-expanded hematopoietic stem cells derived from human umbilical cord blood CD133(+) cells. , 2006, Stem cells and development.
[118] I. Mcniece,et al. Purification of CD34+ cells is essential for optimal ex vivo expansion of umbilical cord blood cells. , 1997, Journal of hematotherapy.
[119] O. Ringdén,et al. Mesenchymal Stem Cells Inhibit the Expression of CD25 (Interleukin‐2 Receptor) and CD38 on Phytohaemagglutinin‐Activated Lymphocytes , 2004, Scandinavian journal of immunology.
[120] J. Reiffers,et al. Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cells , 1999, The Lancet.
[121] S. Gerson,et al. Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. , 2000, Journal of hematotherapy & stem cell research.
[122] W. Piacibello,et al. Differential growth factor requirement of primitive cord blood hematopoietic stem cell for self-renewal and amplification vs proliferation and differentiation , 1998, Leukemia.
[123] P. Price,et al. Prompt and durable engraftment in two older adult patients with high risk chronic myelogenous leukemia (CML) using ex vivo expanded and unmanipulated unrelated umbilical cord blood , 2000, Bone Marrow Transplantation.
[124] O. Ringdén,et al. Mesenchymal Stem Cells Inhibit and Stimulate Mixed Lymphocyte Cultures and Mitogenic Responses Independently of the Major Histocompatibility Complex , 2003, Scandinavian journal of immunology.
[125] E. Fuchs,et al. Socializing with the Neighbors Stem Cells and Their Niche , 2004, Cell.
[126] J. Adamson,et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. , 1998, The New England journal of medicine.
[127] P. Szabolcs,et al. Ex vivo expansion and Th1/Tc1 maturation of umbilical cord blood T cells by CD3/CD28 costimulation. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[128] M. Koller,et al. Clinical-scale human umbilical cord blood cell expansion in a novel automated perfusion culture system , 1998, Bone Marrow Transplantation.
[129] Yang Liu,et al. Ex vivo expansion of hematopoietic stem cells derived from umbilical cord blood in rotating wall vessel. , 2006, Journal of biotechnology.
[130] Lesley J. Murray,et al. Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal. , 2004, Cytotherapy.